Brentuximab Vedotin in Patients at Increased Risk of Hodgkin Lymphoma Progression Post Autologous Stem Cell Transplant: Evaluation of Healthcare Resource Utilization in the Aethera Trial
Authors
Bonthapally, VMa, E
Viviani, S
Radford, John A
Brice, P
von Tresckow, B
Thomas, E
Teasell, J
Gnanasakthy, A
Odom, D
Zhu, Y
Lee, S
Carlson, P
Huebner, D
Sweetenham, J
Moskowitz, C
Walewski, J
Affiliation
Takeda PharmaceuticalIssue Date
2015